Articles with public access mandates - Webster CaveneeLearn more
OverallNIHNSFCDoDHHMICancer Research UKGovernment of SpainNSFNHMRCWellcomeDoris Duke Charitable FoundationV Foundation, USAVAARCCIHRHelmholtzDNRFAcademy of FinlandTekesCSIRDSTSwedish Research CouncilA*StarMRCEuropean CommissionRCNANRNMRCCPRITMelanoma Research AllianceAmerican Brain Tumor AssociationSusan G. Komen
Not available anywhere: 5
Glioblastoma: from molecular pathology to targeted treatment
TF Cloughesy, WK Cavenee, PS Mischel
Annual review of pathology: mechanisms of disease 9 (1), 1-25, 2014
Mandates: US National Institutes of Health
mTOR complex 2 is an integrator of cancer metabolism and epigenetics
K Masui, M Harachi, WK Cavenee, PS Mischel, N Shibata
Cancer letters 478, 1-7, 2020
Mandates: US National Institutes of Health
Dual regulation of histone methylation by mTOR complexes controls glioblastoma tumor cell growth via EZH2 and SAM
M Harachi, K Masui, H Honda, Y Muragaki, T Kawamata, WK Cavenee, ...
Molecular Cancer Research 18 (8), 1142-1152, 2020
Mandates: US National Institutes of Health
mTORC2 activity in brain cancer: Extracellular nutrients are required to maintain oncogenic signaling
K Masui, N Shibata, WK Cavenee, PS Mischel
BioEssays 38 (9), 839-844, 2016
Mandates: US National Institutes of Health
Lab-cell biology and signaling
V Rodriguez-Cruz, J Munoz, P Rameshwar, D Mustafa, A Sieuwerts, ...
Neuro-oncology 14 (Suppl 6), vi7-vi20, 2012
Mandates: US National Institutes of Health
Available somewhere: 98
The 2016 World Health Organization classification of tumors of the central nervous system: a summary
DN Louis, A Perry, G Reifenberger, A Von Deimling, D Figarella-Branger, ...
Acta neuropathologica 131, 803-820, 2016
Mandates: Helmholtz Association
Emerging insights into the molecular and cellular basis of glioblastoma
GP Dunn, ML Rinne, J Wykosky, G Genovese, SN Quayle, IF Dunn, ...
Genes & development 26 (8), 756-784, 2012
Mandates: US National Institutes of Health
Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity
KM Turner, V Deshpande, D Beyter, T Koga, J Rusert, C Lee, B Li, ...
Nature 543 (7643), 122-125, 2017
Mandates: US National Science Foundation, US National Institutes of Health, Susan G. Komen
Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma
R Bonavia, A Mukasa, Y Narita, DWY Sah, S Vandenberg, C Brennan, ...
Genes & development 24 (16), 1731-1745, 2010
Mandates: US National Institutes of Health
Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA
DA Nathanson, B Gini, J Mottahedeh, K Visnyei, T Koga, G Gomez, ...
Science 343 (6166), 72-76, 2014
Mandates: US National Institutes of Health
Heterogeneity maintenance in glioblastoma: a social network
R Bonavia, MM Inda, WK Cavenee, FB Furnari
Cancer research 71 (12), 4055-4060, 2011
Mandates: US National Institutes of Health, Government of Spain
mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc
K Masui, K Tanaka, D Akhavan, I Babic, B Gini, T Matsutani, A Iwanami, ...
Cell metabolism 18 (5), 726-739, 2013
Mandates: US National Institutes of Health
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
FB Furnari, TF Cloughesy, WK Cavenee, PS Mischel
Nature Reviews Cancer 15 (5), 302-310, 2015
Mandates: US National Institutes of Health
Oncogenic EGFR signaling activates an mTORC2–NF-κB pathway that promotes chemotherapy resistance
K Tanaka, I Babic, D Nathanson, D Akhavan, D Guo, B Gini, J Dang, ...
Cancer discovery 1 (6), 524-538, 2011
Mandates: US National Institutes of Health
EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma
B Mukherjee, B McEllin, CV Camacho, N Tomimatsu, S Sirasanagandala, ...
Cancer research 69 (10), 4252-4259, 2009
Mandates: US National Institutes of Health
An LXR-cholesterol axis creates a metabolic co-dependency for brain cancers
GR Villa, JJ Hulce, C Zanca, J Bi, S Ikegami, GL Cahill, Y Gu, KM Lum, ...
Cancer cell 30 (5), 683-693, 2016
Mandates: US National Institutes of Health
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3
A Salameh, AK Lee, M Cardó-Vila, DN Nunes, E Efstathiou, FI Staquicini, ...
Proceedings of the National Academy of Sciences 112 (27), 8403-8408, 2015
Mandates: US National Institutes of Health
A Drosophila Model for EGFR-Ras and PI3K-Dependent Human Glioma
RD Read, WK Cavenee, FB Furnari, JB Thomas
PLoS genetics 5 (2), e1000374, 2009
Mandates: US National Institutes of Health
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
R Bonavia, MM Inda, S Vandenberg, SY Cheng, M Nagane, P Hadwiger, ...
Oncogene 31 (36), 4054-4066, 2012
Mandates: US National Institutes of Health, Government of Spain
EGFR mutation promotes glioblastoma through epigenome and transcription factor network remodeling
F Liu, GC Hon, GR Villa, KM Turner, S Ikegami, H Yang, Z Ye, B Li, ...
Molecular cell 60 (2), 307-318, 2015
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program